Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11883-022-01079-7.pdf
Reference34 articles.
1. Hermel M, Tsai S, Dlouhy L, B KA, Rana JS, Dani SS, et al. Highlights of cardiovascular disease prevention studies presented at the 2022 American College of Cardiology scientific sessions. Curr Atheroscler Rep. 2022;24(8):671–80.
2. Hermel M, Pelter M, Jordan T, Latif A, Gad MM, Slipczuk L, et al. Highlights of cardiovascular disease prevention studies presented at the 2022 European Society of Cardiology Congress. Curr Atheroscler Rep. 2022:1–13.
3. Lee MT, George J, Shahab H, Hermel M, Rana JS, Virani SS. Highlights of cardiovascular disease studies presented at the 2021 American Heart Association scientific sessions. Curr Atheroscler Rep. 2022;24(1):61–72.
4. • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. The Lancet. 2005;366(9500):1849–61. Laid the groundwork and provides context for the studies reviewed here.
5. • Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365(24):2255–67. Laid the groundwork and provides context for the studies reviewed here.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference;Current Atherosclerosis Reports;2024-06-03
2. Efficacy and Safety of Inclisiran, Alirocumab, Evolocumab, and Evinacumab in Lipid-Lowering: A Network Meta-Analysis;2024-04-17
3. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American Heart Association Scientific Sessions;Current Atherosclerosis Reports;2024-03-05
4. Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease;Pharmacoepidemiology;2024-03-05
5. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress;Current Atherosclerosis Reports;2023-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3